Analyst
William Blair
Equibles does not estimate personal net worth.
Steven Lichtman is recorded as Analyst at William Blair. Steven Lichtman has spoken on 13 earnings calls and 1 other investor event across 9 companies, most recently for Dexcom Inc on October 29, 2026. Those appearances were for Sight Sciences, Inc. (SGHT), GLAUKOS Corp (GKOS), Alcon Inc (ALC), Zimmer Biomet Holdings, Inc. (ZBH), Dexcom Inc (DXCM) and 4 other companies. The companies whose calls Steven Lichtman spoke on are classified in the Healthcare sector.
“Jake, you mentioned the upcoming ADA Standards of Care update. Where do you hope that lands now with Connect in hand and published, and do the potential changes there give you more confidence in the ultimate coverage decision by CMS?”
“Joe, you mentioned the KC screening device launch in 27. Can you talk a little bit more about how you'll deploy and leverage that? Let's go into optometrist's office, into screening centers, I think you mentioned.”
“David, coming back to end market health, are there any changes that you're seeing in U.S. consumer sentiment on the IOL side or within contact lenses? You mentioned premium IOL up year over year, so I assume that's okay.”
“Damien, I appreciate your comments now one year in. You mentioned evaluating opportunities without losing focus on cash flow. Think about portfolio management. And again, without losing focus on cash flow, which is, of course, important.”
“Yvonne, you touched on M&A and your prepared remarks. With Paragon now fully in the fold, could you give us your latest thoughts on the type of deal that makes sense for Zimmer Biomet right now?”
William Blair
Analyst
Source not stated
SGHT
Medical Devices · Healthcare
GKOS
Medical Devices · Healthcare
ALC
Medical Instruments & Supplies · Healthcare
DXCM
Medical Devices · Healthcare
ENOV
Medical Devices · Healthcare
RXST
Medical Devices · Healthcare
SYK
Medical Devices · Healthcare
